<ol class="cite-this-references"><li id="reference-A190204">Khan KM, Patel J, Schaefer TJ: Nifedipine . [<a href="/articles/A190204" target="_blank">Article</a>] </li><li id="reference-A190207">Otto J, Lesko LJ: Protein binding of nifedipine. J Pharm Pharmacol. 1986 May;38(5):399-400. doi: 10.1111/j.2042-7158.1986.tb04598.x. [<a href="/articles/A190207" target="_blank">Article</a>] </li><li id="reference-A190210">Chung M, Reitberg DP, Gaffney M, Singleton W: Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine. Am J Med. 1987 Dec 21;83(6B):10-4. doi: 10.1016/0002-9343(87)90630-9. [<a href="/articles/A190210" target="_blank">Article</a>] </li><li id="reference-A190219">Herrington DM, Insley BM, Weinmann GG: Nifedipine overdose. Am J Med. 1986 Aug;81(2):344-6. doi: 10.1016/0002-9343(86)90276-7. [<a href="/articles/A190219" target="_blank">Article</a>] </li><li id="reference-A190222">Whitebloom D, Fitzharris J: Nifedipine overdose. Clin Cardiol. 1988 Jul;11(7):505-6. doi: 10.1002/clc.4960110714. [<a href="/articles/A190222" target="_blank">Article</a>] </li><li id="reference-A190228">Raemsch KD, Sommer J: Pharmacokinetics and metabolism of nifedipine. Hypertension. 1983 Jul-Aug;5(4 Pt 2):II18-24. doi: 10.1161/01.hyp.5.4_pt_2.ii18. [<a href="/articles/A190228" target="_blank">Article</a>] </li><li id="reference-A190225">Waller DG, Renwick AG, Gruchy BS, George CF: The first pass metabolism of nifedipine in man. Br J Clin Pharmacol. 1984 Dec;18(6):951-4. doi: 10.1111/j.1365-2125.1984.tb02569.x. [<a href="/articles/A190225" target="_blank">Article</a>] </li><li id="reference-A190261">Nader AM, Quinney SK, Fadda HM, Foster DR: Effect of Gastric Fluid Volume on the In Vitro Dissolution and In Vivo Absorption of BCS Class II Drugs: a Case Study with Nifedipine. AAPS J. 2016 Jul;18(4):981-8. doi: 10.1208/s12248-016-9918-x. Epub 2016 Apr 22. [<a href="/articles/A190261" target="_blank">Article</a>] </li><li id="reference-A190264">van Harten J, Burggraaf K, Danhof M, van Brummelen P, Breimer DD: Negligible sublingual absorption of nifedipine. Lancet. 1987 Dec 12;2(8572):1363-5. doi: 10.1016/s0140-6736(87)91258-x. [<a href="/articles/A190264" target="_blank">Article</a>] </li><li id="reference-A190273">Wang AL, Iadecola C, Wang G: New generations of dihydropyridines for treatment of hypertension. J Geriatr Cardiol. 2017 Jan;14(1):67-72. doi: 10.11909/j.issn.1671-5411.2017.01.006. [<a href="/articles/A190273" target="_blank">Article</a>] </li><li id="reference-A175390">Godfraind T: Discovery and Development of Calcium Channel Blockers. Front Pharmacol. 2017 May 29;8:286. doi: 10.3389/fphar.2017.00286. eCollection 2017. [<a href="/articles/A175390" target="_blank">Article</a>] </li><li id="reference-A190276">Vater W, Kroneberg G, Hoffmeister F, Saller H, Meng K, Oberdorf A, Puls W, Schlossmann K, Stoepel K: [Pharmacology of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (Nifedipine, BAY a 1040)]. Arzneimittelforschung. 1972 Jan;22(1):1-14. [<a href="/articles/A190276" target="_blank">Article</a>] </li><li id="reference-L11383">FDA Approved Drug Products: Procardia Nifedipine Oral Capsules [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/018482s052lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11389">FDA Approved Drug Products: Procardia XL Nifedipine Oral Extended Release Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019684s029lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L1245">FDA Approved Drug Products: Adalat CC Nifedipine Oral Extended Release Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020198s023lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11428">Cayman Chemical: Nifedipine MSDS [<a href="https://www.caymanchem.com/msdss/11106m.pdf" target="_blank">Link</a>] </li></ol>